Virtual screening using the Glide workflow in Schrödinger

Virtual screening using the Glide workflow in Schrödinger is a widely used approach in computational drug discovery. It allows researchers to efficiently screen large chemical libraries against a target protein to identify potential lead compounds. Here's an overview of the virtual screening process using the Glide workflow in Schrödinger:

Virtual screening - Click the link to watch video

 I. Introduction

   A. Definition of Virtual Screening

   B. Importance in Drug Discovery

   C. Role of Glide Workflow

II. Understanding Glide Workflow

   A. Overview of Glide

   B. Key Components

      1. Grid Generation

      2. Ligand Preparation

      3. Receptor Grid Generation

III. Advantages of Virtual Screening

   A. Time Efficiency

   B. Cost-effectiveness

   C. Reduction of False Positives

IV. Setting Up Virtual Screening

   A. Software Requirements

   B. System Specifications

   C. Data Preparation

 V. Glide Workflow in Action

   A. Initiating the Glide Application

   B. Configuring Parameters

      1. Scoring Functions

      2. Sampling Methods

1. Preparing Target Protein:

  • Import the three-dimensional structure of the target protein in a suitable file format (e.g., PDB).
  • Prepare the protein structure by adding missing atoms, assigning bond orders, and optimizing the hydrogen positions.

2. Ligand Library Preparation:

  • Prepare a library of ligands that will be screened against the target protein.
  • Ligands can be obtained from various sources, such as compound databases, commercially available libraries, or in-house collections.
  • Prepare the ligand library by generating three-dimensional conformations, optimizing their geometries, and assigning appropriate charges.

3. Glide Workflow Setup:

  • Open the Schrödinger suite and launch the Glide module.
  • Set up the Glide workflow by specifying the necessary parameters for the docking and scoring calculations.

4. Receptor Grid Generation:

  • Generate a receptor grid that defines the active site or binding site of the target protein.
  • The receptor grid helps guide the docking of ligands into the desired region.

5. Ligand Docking:

  • Perform the docking of ligands into the active site using the Glide workflow.
  • Glide employs a combination of ligand-based and receptor-based docking algorithms to explore ligand conformations and protein-ligand interactions.
  • Multiple docking poses are generated for each ligand to explore different binding modes.

6. Scoring and Ranking:

  • Score and rank the docked ligand poses based on their predicted binding affinities and other scoring criteria.
  • Glide employs a scoring function that considers factors such as shape complementarity, electrostatic interactions, hydrogen bonding, and hydrophobicity.

7. Analysis and Visualization:

  • Analyze the docking results to identify potential lead compounds.
  • Visualize the docked ligand-protein complexes to understand their binding modes and interactions.
  • Further analyze the top-ranked compounds based on docking scores, considering factors like binding affinity, drug-likeness, and chemical properties.

8. Hit Selection and Validation:

  • Select a subset of top-ranked compounds as potential hits for further experimental validation.
  • Experimental techniques such as biochemical assays, cellular assays, or in vivo studies can be conducted to confirm the activity and efficacy of the selected compounds.

Conclusion:

Virtual screening using the Glide workflow in Schrödinger is a powerful tool for efficiently screening large compound libraries and identifying potential lead compounds. It combines ligand-based and receptor-based docking algorithms to predict ligand-protein interactions and ranks the compounds based on their binding affinities. This approach accelerates the drug discovery process by narrowing down the pool of compounds for further experimental validation and optimization.

Previous Post Next Post